BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Thomson J, Hilditch A, Pirkis J, Dunt D. Immunisation initiatives in general practice. Important lessons from division projects. Aust.Fam.Physician
1999;1290­7.
Tiwari RR, Kulkarni PN. Delayed immunization against vaccine preventable diseases­­factors responsible among children under 5 years of age. Indian
J.Med.Sci. 1999;212­5.
Toniolo­Neto J, Weckx LW, Halker E, Lopes CH, Menezes Succi RC, de Paiva TM et al. Safety of simultaneous pneumococcal and influenza vaccination in
elderly patients in Brazil. Drugs Aging 1999; 15 Suppl 1:43­45.
Torzillo P, Dixon J, Manning K, Hutton S, Gratten M, Hueston L, Leinonen M, Morey F, Forsythe S, Num R, Erlich J, Asche V, Cunningham A, Riley I.
Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children. Pediatr.Infect.Dis.J. 1999;714­21.
Tourbah A, Gout O, Liblau R, Lyon­Caen O, Bougniot C, Iba­Zizen MT, Cabanis EA.,.Encephalitis after hepatitis B vaccination: recurrent disseminated
encephalitis or MS? Neurology 1999 Jul 22;53(2):396­401.
Toyota M, Kudo K, Sumiya M, Kobori O. High frequency of individuals with strong reaction to tuberculin among clinical trainees. Jpn.J.Infect.Dis. 1999;128­
9.
Treanor J, Falsey A, Treanor J, Falsey A. Respiratory viral infections in the elderly. Antiviral Res. 1999;79­102.
Tsai HY, Huang LM, Shih YT, Chen JM, Jiang TM, Tsai CH, Lee CY. Immunogenicity and safety of standard­titer AIK­C measles vaccine in nine­month­old
infants. Viral Immunol. 1999;343­8.
Tu HT, Kemper P, Wong HJ. Do HMOs make a difference? Use of health services. Inquiry 1999; 36(4):400­410.
Tu SW, Musen MA. A flexible approach to guideline modeling. Proc.AMIA.Symp. 1999;420­4.
Tucker R. Hepatitis and typhoid vaccine: killing two birds with one stone. Community Nurse 1999; 5(10):41­42.
Tuohy PG. Immunisation coverage in New Zealand [letter]. N.Z.Med.J. 1999;454.
Uilenberg G. Immunization against diseases caused by Theileria parva: a review. Trop.Med.Int.Health 1999;A12­A20.
Umene K. Mechanism and application of genetic recombination in herpesviruses. Rev.Med.Virol. 1999;171­82.
Valiante NM, Rappuoli R, Insel RA, McInnes P, Hoeveler A. The challenges of vaccinating the very young: lessons from a very old system of host defense.
Vaccine 1999;2757­62.
Van Buynder PG, Owen D, Vurdien JE, Andrews NJ, Matthews RC, Miller E. Bordetella pertussis surveillance in England and Wales: 1995­7.
Epidemiol.Infect. 1999;403­11.
van Hattum J, Chen XQ. Hepatitis A: infection, detection, vaccination and immunity. Neth.J.Med. 1999;142­50.
Van Herck K, Van Damme P, Collard F, Thoelen S. Two­dose combined vaccination against hepatitis A and B in healthy subjects aged 11­18 years.
Scand.J.Gastroenterol. 1999;1236­40.
Van Steenbergen, J. E., Spanjaard, L., and Kraayeveld, A. G. Vaccination Campaign for Meningococcal Disease in a Rural Area in the Netherlands ­ January
1998. Euro.Surveill 1999, 4 (2): 18­21.
Vellinga A, Van Damme P, Meheus A. Hepatitis B and C in institutions for individuals with intellectual disability. J.Intellect.Disabil.Res. 1999;445­53.
Vyas SP, Sihorkar V. Exploring novel vaccines against Helicobacter pylori: protective and therapeutic immunization. J.Clin.Pharm.Ther. 1999;259­72.
Wadsworth L. Polio immunization: dealing with new recommendations and helping parents understand the changes. J Pediatr Health Care 1999 Nov­1999 Dec
31;13(6 Pt 2):S21­30.
Wagstaff A, Brooke G. Prophylactic anti­infective vaccines in clinical development. Summary and table. Drugs R.D. 1999;185­91.
Wakefield AJ, Montgomery SM. Autism, viral infection and measles­mumps­rubella vaccination [comment]. Isr Med Assoc J 1999; 1(3):183­187.
Wang D, Jenders RA, Dasgupta B. Translating national childhood immunization guidelines to a computer­based reminder recall system within an
immunization registry. Proc.AMIA.Symp. 1999;994­8.
Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications.
Clin.Microbiol.Rev. 1999;633­53.
Warner J. Immunising children is difficult for parents, but it is worse for nurses. Nurs.Times 1999;17.
Watanabe M. PACHA adopts more lenient stance to government efforts [news]. Nat.Med. 1999;1220­1.
Watson DA, Musher DM. A brief history of the pneumococcus in biomedical research. Semin.Respir.Infect. 1999;198­208.
Wenger JD, DiFabio J, Landaverde JM, Levine OS, Gaafar T. Introduction of Hib conjugate vaccines in the non­industrialized world: experience in four
'newly adopting' countries. Vaccine 1999;736­42.
Whang W, Sisk JE, Heitjan DF, Moskowitz AJ. Probabilistic sensitivity analysis in cost­effectiveness. An application from a study of vaccination against
pneumococcal bacteremia in the elderly. Int J Technol Assess Health Care 1999 Summer;15(3):563­72.
White F. Prior use of killed vaccine as a factor in measles incidence in Canada [letter]. Int.J.Epidemiol. 1999;1185­6.
White F. Prior use of killed vaccine as a factor in measles incidence in Canada. Int J Epidemiol. 1999 Dec;28(6):1185­6.
White H. Association between type 1 diabetes and Hib vaccine. More research is still needed. BMJ. 1999 Oct 23;319(7217):1133.
Whittle HC, Aaby P, Samb B, Jensen H, Bennett J, Simondon F. Effect of subclinical infection on maintaining immunity against measles in vaccinated
children in West Africa. Lancet 1999 Jan 9;353(9147):98­102.
Widdus R. Introduction of vaccines into the Third World. C.R.Acad.Sci.III 1999;999­1010.
Williams CH. Durban Malaria Conference­­a short report [letter]. S Afr Med J 1999; 89(12):1240.
Wood JM, Major D, Daly J, Newman RW, Dunleavy U, Nicolson C, Robertson JS, Schild GC, Lee­Lin YN. Vaccines against H5N1 influenza [letter].
Vaccine 1999;579­80.
Wynter SH, O'Gilvie CR, Khan C, Brown MG, Lindo JF, King SD. Rubella susceptibility in Jamaican women, 1996. West Indian Med.J. 1999;123­5.
Yalcin SS, Yurdakok K. Sex­specific differences in serum vitamin A values after measles immunization [letter]. Pediatr.Infect.Dis.J. 1999;747­8.
Yan J, Provost GP. North Carolina vaccine program linked to improved childhood immunization rates [news]. Am.J.Health Syst.Pharm. 1999;2019.
Yarbough PO. Hepatitis E virus. Advances in HEV biology and HEV vaccine approaches. Intervirology 1999;179­84.
Yusuf HR, Coronado VG, Averhoff FA, Maes EF, Rodewald LE, Battaglia MP, Mahoney FJ. Progress in coverage with hepatitis B vaccine among US
children, 1994­1997. Am.J.Public Health 1999;1684­9.
Zahner SJ. Public health nursing and immunization surveillance. Public Health Nurs. 1999;384­9.
Zarzuela­Ramirez M, Cordoba­Dona JA, Perea­Milla E, Benitez­Rodriguez E, Escolar­Pujolar A, Lopez­Fernandez FJ. Factors associated with tuberculin
conversion among staff at a university­affiliated hospital [letter]. Infect.Control Hosp.Epidemiol. 1999;589­90.
Zegers ND, Kluter E, van Der SH, van Dura E, van Dalen P, Shaw M, Baillie L. Expression of the protective antigen of Bacillus anthracis by Lactobacillus
casei: towards the development of an oral vaccine against anthrax. J.Appl.Microbiol. 1999;309­14.
Zimmerman RK, Ahwesh ER. Using problem­based learning to target public health problems. Acad.Med. 1996;543.
Zoon KC. Vaccines, pharmaceutical products, and bioterrorism: challenges for the U.S. Food and Drug Administration. Emerg.Infect.Dis. 1999;534­6.
Zotti C, Ossola O, Barberis R, Castella A, Ruggenini AM. Mumps: a current epidemiologic pattern as a necessary background for the choice of a vaccination
strategy. Eur.J.Epidemiol. 1999;659­63.
2000
Feikema SM, Klevens RM, Washington ML, Barker L. Extraimmunization among US children [see comments]. JAMA 2000;1311­7.